Endovascular Therapy and Outcomes Among Patients With Very Large Ischemic Core Stroke

Importance The association of endovascular therapy (EVT) with outcomes is unclear for patients with very low Alberta Stroke Program Early Computed Tomography Score (ASPECTS) within 24 hours of stroke onset. Objective To explore the association of EVT with functional and safety outcomes among patients with ASPECTS of 0 to 2 scored with noncontrast computed tomography. Design, Setting, and Participants This cohort study used data from an ongoing, prospective, observational, nationwide registry including all patients treated at 38 stroke centers in China with an occlusion in the internal carotid artery or M1 or M2 segment of the middle cerebral artery within 24 hours of witnessed symptom onset. Patients with ASPECTS of 0 to 2 between November 1, 2021, and February 8, 2023, were included in analysis. Data were analyzed October to November 2023. Exposures EVT vs standard medical treatment (SMT). Main Outcomes and Measures The primary outcome was favorable functional outcome, defined as modified Rankin Scale score (mRS) of 0 to 3, at 90 days. Safety outcomes included symptomatic intracerebral hemorrhage (sICH) within 48 hours and mortality at 90 days. Results A total of 245 patients (median IQR age, 71 63-78 years; 118 48% women) with ASPECTS of 0 to 2 were included, of whom 111 patients (45.1%) received SMT and 135 patients (54.9%) received EVT. The EVT group had significantly greater odds of favorable functional outcome at 90 days than the SMT group (30 patients 22.2% vs 11 patients 9.9%; P = .01; adjusted odds ratio aOR, 3.07 95% CI, 1.29-7.31; P = .01). Patients in the EVT group, compared with the SMT group, had significantly greater odds of any ICH (56 patients 41.5% vs 16 patients 11.4%; P lt; .001; aOR, 4.27 95% CI, 2.19-8.35; P lt; .001) and sICH (24 patients 17.8% vs 1 patient 0.9%; P lt; .001; aOR, 23.07 95% CI, 2.99-177.79; P = .003) within 48 hours. There were no differences between groups for 90-day mortality (80 patients 59.3% vs 59 patients 53.2%; P = .34; aOR, 1.38 95% CI, 0.77-2.47; P = .28). The results remained robust in the propensity score–matched analysis. Conclusions and Relevance In this cohort study of patients with very low ASPECTS based on NCCT within 24 hours of stroke onset, those treated with EVT had higher odds of a favorable functional outcome compared with those who received SMT. Randomized clinical trials are needed to assess these findings.